Burns Matteson Capital Management, LLC Laboratory Corp Of America Holdings Transaction History

Burns Matteson Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 11, 2023	SELL	$211.93 - $241.33 $563,733 - $641,937	-2,660 Closed	0 $0
Q1 2023 Dec 11, 2023	SELL	$213.32 - $257.83 $10,239 - $12,375	-48 Reduced 1.77%	2,660 $610 Million
Q4 2022 Dec 11, 2023	BUY	$203.72 - $248.97 $551,673 - $674,210	2,708 New	2,708 $638 Million
Q3 2022 Dec 11, 2023	SELL	$204.81 - $262.19 $586,371 - $750,649	-2,863 Closed	0 $0
Q2 2022 Dec 11, 2023	BUY	$213.86 - $277.87 $612,281 - $795,541	2,863 New	2,863 $671 Million
Q3 2021 Dec 11, 2023	SELL	$274.82 - $308.34 $365,785 - $410,400	-1,331 Closed	0 $0
Q2 2021 Dec 11, 2023	BUY	$251.87 - $278.14 $114,600 - $126,553	455 Added 51.94%	1,331 $367 Million
Q1 2021 Dec 11, 2023	BUY	$204.88 - $255.03 $179,474 - $223,406	876 New	876 $223 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.